IP Library › Assignment 026400/0132
Patent Assignment
Reel/Frame 026400/0132

Assignment of Assignor's Interest

Recorded: 2011-06-07 Pages: 4
Assignor
Assignee
BELLUS HEALTH INC.
275 ARMAND-FRAPPIER BOULEVARD, LAVAL, QUEBEC, H7V 4A7, CANADA
Covered Properties (2)
Pharmaceutical formulations of amyloid inhibiting compounds
Application: 11/103,656 →
Publication: US 2006/0079578
Pharmaceutical Formulations of Amyloid Inhibiting Compounds
Patent: 8,835,500 →
Application: 12/362,971 →
Publication: US 2009/0182056
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 23, 2005
From: LAURIN, JULIE; GARCEAU, DENIS
To: NEUROCHEM (INTERNATIONAL) LIMITED
Reel/Frame 017401/0709 →
Change of Name Mar 24, 2009
From: NEUROCHEM (INTERNATIONAL) LIMITED
To: BELLUS HEALTH (INTERNATIONAL) LIMITED
Reel/Frame 022439/0021 →
Assignment of Assignor's Interest Aug 9, 2012
From: BELLUS HEALTH INC.
To: BHI LIMITED PARTNERSHIP
Reel/Frame 028758/0266 →
Assignment of Assignor's Interest Dec 5, 2017
From: BHI LIMITED PARTNERSHIP
To: THALLION PHARMACEUTICALS INC.; BELLUS HEALTH INC.
Reel/Frame 044296/0094 →
Assignment of Assignor's Interest Dec 5, 2017
From: THALLION PHARMACEUTICALS INC.
To: BELLUS HEALTH INC.
Reel/Frame 044296/0140 →